🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
46.53
+0.12 (0.26%)
Nov 20, 2026, 4:00 PM EST - Market closed

Enliven Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
151.6798.9124.12100.1475.54110.02
Short-Term Investments
732.68363.73189.32153.01--
Cash & Short-Term Investments
884.35462.62313.44253.1575.54110.02
Cash Growth
85.18%47.59%23.82%235.14%-31.35%-15.60%
Prepaid Expenses
10.4112.264.632.952.220.65
Restricted Cash
--0.050.05--
Other Current Assets
---10--
Total Current Assets
894.76474.88318.13266.1577.75110.67
Property, Plant & Equipment
1.510.420.461.061.520.95
Long-Term Deferred Charges
-0.22-0.563.981.65
Other Long-Term Assets
0.960.667.184.090.050.05
Total Assets
897.23476.17325.76271.8783.3113.33

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2.732.161.340.533.442.52
Accrued Expenses
16.0613.6614.3714.664.322.84
Current Portion of Leases
0.510.4-0.340.320.16
Other Current Liabilities
0.170.350.210.361.640.23
Total Current Liabilities
19.4716.5715.9225.899.725.75
Long-Term Leases
0.81---0.28-
Other Long-Term Liabilities
---0.070.380.71
Total Liabilities
20.2816.5715.9225.9610.376.47

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.070.060.050.0400
Additional Paid-In Capital
1,311806.37553.21400.176.042.31
Retained Earnings
-430.98-347.17-243.47-154.45-82.86-45.2
Comprehensive Income & Other
-3.510.330.060.14--
Total Common Equity
876.95459.6309.85245.91-76.83-42.89
Shareholders' Equity
876.95459.6309.85245.9172.92106.86
Total Liabilities & Equity
897.23476.17325.76271.8783.3113.33

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1.320.4-0.340.60.16
Net Cash (Debt)
883.04462.22313.44252.8174.94109.87
Net Cash Growth
85.09%47.47%23.98%237.37%-31.79%-15.66%
Net Cash Per Share
13.118.166.667.1123.9914.06
Filing Date Shares Outstanding
73.659.84941.3512.111.64
Total Common Shares Outstanding
73.5659.4448.9441.2912.111.64
Working Capital
875.28458.31302.21240.2668.04104.92
Book Value Per Share
11.927.736.335.96-6.35-3.68
Tangible Book Value
876.95459.6309.85245.91-76.83-42.89
Tangible Book Value Per Share
11.927.736.335.96-6.35-3.68
Machinery
0.450.261.381.411.260.65
SEC Filings: 10-K · 10-Q